Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease
NCT01614574
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease
Interventions
BIOLOGICAL:
velaglucerase alfa
Sponsor
Shire